Valuation
- Market cap
- 11,646,442,000
- Revenue TTM
- $3,477,810,000
- Net income TTM
- $233,910,000
- PE ratio
- 0.00
- Forward PE
- 25.00
- Profit margin
- 6.73%
- Debt to equity
- 1.77
Trading
- Volume
- 200
- Avg volume
- 768
- Day's range
- $27.50 – $27.50
- Shares out
- 423,507,000
- Stochastic %K
- 87%
- Beta
- 1.16
- Analysts
- Sell
- Price target
- $87.89
Company profile
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed...
Show more
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 45 39 17 73 00
- Website
- https://www.demant.com
- Address
- Kongebakken 9, Smørum, Denmark
Latest news
No headlines yet.
